By Beth Newcomb
New findings about how cell signaling directs tongue development may have big clinical applications for healing tongue defects, according to an Ostrow School of Dentistry of USC study in the Journal of Biological Chemistry.
Yang Chai, DDS, PhD, principal investigator of “Non-canonical transforming growth factor beta (TGFb) signaling in cranial neural crest cells causes tongue muscle developmental defects” and director of the Center for Craniofacial Molecular Biology at the Ostrow School of Dentistry, said the tongue is a unique, highly mobile muscular organ that many view as a “fifth limb.” When the tongue develops improperly or is damaged by injury or disease, it cannot regenerate on its own.
“The current standard of care is to repair the tongue surgically using a skin flap, but it doesn’t have the muscle components to move the tongue and lacks the ability to taste food,” explained Chai. “We want to understand how the tongue is formed and how we can use that knowledge to regenerate the tongue.”
A specialized group of cells called cranial neural crest (CNC) cells are responsible for the growth of many aspects of the mouth and face as an embryo develops. CNC cells not only form a scaffold of connective tissue for new tongue muscle cells, but also secrete necessary growth factors, including transforming growth factor beta (TGFb).
Using mouse tissue as an experimental model, the study showed that a mutation in TGFb causes the growth factor to trigger an abnormal cascade of cellular signals, resulting in defects such as microglossia, or small tongue, Chai said.
Promisingly, malformed tongue muscle cells were rescued and restored when proper growth factors were reintroduced to the cells. With such striking success in vitro, the next step is to examine the process in a live animal model, he noted.
“If you want to repair a tongue defect, you could possibly use some of these growth factors to guide the muscle and improve surgical success,” Chai said.
The study was honored as a “Paper of the Week,” which means that it was among the top 2 percent of the more than 6,000 papers published by the Journal of Biological Chemistry each year. Chai said he and his team are honored by the distinction and credits focusing on translational science for their continued research success.
“Not only do we have a story to tell about the signaling, but this study also clearly has some clinical applications,” he said.